{
  "ticker": "AMGN",
  "last_updated": "2025-04-15T14:53:27.739286",
  "retention_years": 3,
  "count": 377,
  "transactions": [
    {
      "id": 84866,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6240"
    },
    {
      "id": 84867,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14868"
    },
    {
      "id": 84888,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11655"
    },
    {
      "id": 84890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5825"
    },
    {
      "id": 84899,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3400.635"
    },
    {
      "id": 84901,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1899.7339"
    },
    {
      "id": 84903,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11208.9807"
    },
    {
      "id": 84936,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5688"
    },
    {
      "id": 84939,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "22465"
    },
    {
      "id": 84948,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "SUGAR RONALD D",
      "reporting_owner_cik": "0001216519",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19682"
    },
    {
      "id": 84953,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7978.6716"
    },
    {
      "id": 84971,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-19",
      "transaction_shares": "939",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3115"
    },
    {
      "id": 84861,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2023-05-05",
      "transaction_shares": "594",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "54114"
    },
    {
      "id": 84902,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2023-05-05",
      "transaction_shares": "579",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "63582"
    },
    {
      "id": 84934,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2023-05-05",
      "transaction_shares": "39",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "7581"
    },
    {
      "id": 84937,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2023-05-05",
      "transaction_shares": "54",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "14224"
    },
    {
      "id": 84946,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2023-05-05",
      "transaction_shares": "51",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "7553"
    },
    {
      "id": 84950,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2023-05-05",
      "transaction_shares": "623",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "53866"
    },
    {
      "id": 84957,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2023-05-05",
      "transaction_shares": "608",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "31990"
    },
    {
      "id": 84960,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2023-05-05",
      "transaction_shares": "16",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "9966"
    },
    {
      "id": 84979,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2023-05-05",
      "transaction_shares": "2083",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "641734"
    },
    {
      "id": 84987,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2023-05-05",
      "transaction_shares": "592",
      "transaction_price": "231.89",
      "transaction_type": "F",
      "shares_after_transaction": "39573"
    },
    {
      "id": 84884,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-02",
      "transaction_shares": "137.7294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2461.635"
    },
    {
      "id": 84886,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2023-05-02",
      "transaction_shares": "3814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "32598"
    },
    {
      "id": 84892,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2023-05-02",
      "transaction_shares": "13486",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "646680"
    },
    {
      "id": 84906,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2023-05-02",
      "transaction_shares": "1101",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7661"
    },
    {
      "id": 84911,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2023-05-02",
      "transaction_shares": "3559",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64877"
    },
    {
      "id": 84914,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2023-05-02",
      "transaction_shares": "3814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55527"
    },
    {
      "id": 84921,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2023-05-02",
      "transaction_shares": "635",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14340"
    },
    {
      "id": 84930,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-02",
      "transaction_shares": "137.7294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "960.7339"
    },
    {
      "id": 84955,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2023-05-02",
      "transaction_shares": "4237",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55348"
    },
    {
      "id": 84964,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-02",
      "transaction_shares": "169.5131",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7039.6716"
    },
    {
      "id": 84965,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2023-05-02",
      "transaction_shares": "3390",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "40767"
    },
    {
      "id": 84975,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2023-05-02",
      "transaction_shares": "593",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7677"
    },
    {
      "id": 84982,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2023-05-02",
      "transaction_shares": "423",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10002"
    },
    {
      "id": 84862,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2023-04-30",
      "transaction_shares": "50",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "6560"
    },
    {
      "id": 84863,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2023-04-30",
      "transaction_shares": "666",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "51713"
    },
    {
      "id": 84873,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2023-04-30",
      "transaction_shares": "73",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "13705"
    },
    {
      "id": 84874,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2023-04-30",
      "transaction_shares": "660",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "61318"
    },
    {
      "id": 84875,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2023-04-30",
      "transaction_shares": "664",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "37377"
    },
    {
      "id": 84877,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2023-04-30",
      "transaction_shares": "2208",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "633194"
    },
    {
      "id": 84894,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2023-04-30",
      "transaction_shares": "728",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "51111"
    },
    {
      "id": 84908,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2023-04-30",
      "transaction_shares": "47",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "7084"
    },
    {
      "id": 84970,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2023-04-30",
      "transaction_shares": "583",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "28784"
    },
    {
      "id": 84972,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2023-04-30",
      "transaction_shares": "27",
      "transaction_price": "239.74",
      "transaction_type": "F",
      "shares_after_transaction": "9579"
    },
    {
      "id": 49700,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3785",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "38041"
    },
    {
      "id": 49703,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2023-03-17",
      "transaction_shares": "339",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 49708,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3978",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "52379"
    },
    {
      "id": 49732,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2023-03-17",
      "transaction_shares": "96",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "9606"
    },
    {
      "id": 49733,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3978",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "51839"
    },
    {
      "id": 49735,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2023-03-17",
      "transaction_shares": "13971",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "635402"
    },
    {
      "id": 49752,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2023-03-17",
      "transaction_shares": "241",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "7103"
    },
    {
      "id": 49753,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3881",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "61978"
    },
    {
      "id": 49764,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3403",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "29367"
    },
    {
      "id": 49768,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2023-03-17",
      "transaction_shares": "322",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "6610"
    },
    {
      "id": 84882,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3785",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "38041"
    },
    {
      "id": 84887,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2023-03-17",
      "transaction_shares": "339",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 84896,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3978",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "52379"
    },
    {
      "id": 84929,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2023-03-17",
      "transaction_shares": "96",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "9606"
    },
    {
      "id": 84931,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3978",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "51839"
    },
    {
      "id": 84933,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2023-03-17",
      "transaction_shares": "13971",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "635402"
    },
    {
      "id": 84961,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2023-03-17",
      "transaction_shares": "241",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "7103"
    },
    {
      "id": 84962,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3881",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "61978"
    },
    {
      "id": 84980,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2023-03-17",
      "transaction_shares": "3403",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "29367"
    },
    {
      "id": 84985,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2023-03-17",
      "transaction_shares": "322",
      "transaction_price": "234.57",
      "transaction_type": "F",
      "shares_after_transaction": "6610"
    },
    {
      "id": 49697,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2023-03-06",
      "transaction_shares": "920",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6905"
    },
    {
      "id": 49705,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7947",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "56167"
    },
    {
      "id": 49711,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7753",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "32541"
    },
    {
      "id": 49716,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2023-03-06",
      "transaction_shares": "27915",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "648712"
    },
    {
      "id": 49721,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2023-03-06",
      "transaction_shares": "387",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9679"
    },
    {
      "id": 49728,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7947",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55621"
    },
    {
      "id": 49731,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7560",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "41620"
    },
    {
      "id": 49740,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2023-03-06",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14032"
    },
    {
      "id": 49741,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7753",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65676"
    },
    {
      "id": 49766,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2023-03-06",
      "transaction_shares": "687",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7338"
    },
    {
      "id": 84879,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2023-03-06",
      "transaction_shares": "920",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6905"
    },
    {
      "id": 84891,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7947",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "56167"
    },
    {
      "id": 84900,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7753",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "32541"
    },
    {
      "id": 84910,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2023-03-06",
      "transaction_shares": "27915",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "648712"
    },
    {
      "id": 84917,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2023-03-06",
      "transaction_shares": "387",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9679"
    },
    {
      "id": 84925,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7947",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55621"
    },
    {
      "id": 84928,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7560",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "41620"
    },
    {
      "id": 84942,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2023-03-06",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14032"
    },
    {
      "id": 84943,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2023-03-06",
      "transaction_shares": "7753",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65676"
    },
    {
      "id": 84983,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2023-03-06",
      "transaction_shares": "687",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7338"
    },
    {
      "id": 26182,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-11-09",
      "transaction_shares": "387",
      "transaction_price": "292.90",
      "transaction_type": "S",
      "shares_after_transaction": "6630"
    },
    {
      "id": 49734,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-11-09",
      "transaction_shares": "387",
      "transaction_price": "292.90",
      "transaction_type": "S",
      "shares_after_transaction": "6630"
    },
    {
      "id": 84932,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-11-09",
      "transaction_shares": "387",
      "transaction_price": "292.90",
      "transaction_type": "S",
      "shares_after_transaction": "6630"
    },
    {
      "id": 26198,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "222.3058",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10112.9807"
    },
    {
      "id": 26200,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "171.0045",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "810.0045"
    },
    {
      "id": 26206,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "222.3058",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2301.9056"
    },
    {
      "id": 49755,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "222.3058",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10112.9807"
    },
    {
      "id": 49757,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "171.0045",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "810.0045"
    },
    {
      "id": 49763,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "222.3058",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2301.9056"
    },
    {
      "id": 84966,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "222.3058",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10112.9807"
    },
    {
      "id": 84968,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "171.0045",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "810.0045"
    },
    {
      "id": 84978,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-08",
      "transaction_shares": "222.3058",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2301.9056"
    },
    {
      "id": 26147,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-11-05",
      "transaction_shares": "45",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "9278"
    },
    {
      "id": 26183,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-11-05",
      "transaction_shares": "63",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "5973"
    },
    {
      "id": 26189,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-11-05",
      "transaction_shares": "240",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "13554"
    },
    {
      "id": 26208,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-11-05",
      "transaction_shares": "168",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "7017"
    },
    {
      "id": 49687,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-11-05",
      "transaction_shares": "45",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "9278"
    },
    {
      "id": 49736,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-11-05",
      "transaction_shares": "63",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "5973"
    },
    {
      "id": 49744,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-11-05",
      "transaction_shares": "240",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "13554"
    },
    {
      "id": 49767,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-11-05",
      "transaction_shares": "168",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "7017"
    },
    {
      "id": 84860,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-11-05",
      "transaction_shares": "45",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "9278"
    },
    {
      "id": 84935,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-11-05",
      "transaction_shares": "63",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "5973"
    },
    {
      "id": 84947,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-11-05",
      "transaction_shares": "240",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "13554"
    },
    {
      "id": 84984,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-11-05",
      "transaction_shares": "168",
      "transaction_price": "269.04",
      "transaction_type": "F",
      "shares_after_transaction": "7017"
    },
    {
      "id": 26190,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-11-02",
      "transaction_shares": "2440",
      "transaction_price": "272.06",
      "transaction_type": "F",
      "shares_after_transaction": "48136"
    },
    {
      "id": 26210,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-11-02",
      "transaction_shares": "125",
      "transaction_price": "272.06",
      "transaction_type": "F",
      "shares_after_transaction": "9323"
    },
    {
      "id": 49745,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-11-02",
      "transaction_shares": "2440",
      "transaction_price": "272.06",
      "transaction_type": "F",
      "shares_after_transaction": "48136"
    },
    {
      "id": 49770,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-11-02",
      "transaction_shares": "125",
      "transaction_price": "272.06",
      "transaction_type": "F",
      "shares_after_transaction": "9323"
    },
    {
      "id": 84949,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-11-02",
      "transaction_shares": "2440",
      "transaction_price": "272.06",
      "transaction_type": "F",
      "shares_after_transaction": "48136"
    },
    {
      "id": 84988,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-11-02",
      "transaction_shares": "125",
      "transaction_price": "272.06",
      "transaction_type": "F",
      "shares_after_transaction": "9323"
    },
    {
      "id": 26187,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1644",
      "transaction_price": "270.35",
      "transaction_type": "F",
      "shares_after_transaction": "33963"
    },
    {
      "id": 26209,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "3030",
      "transaction_price": "270.35",
      "transaction_type": "F",
      "shares_after_transaction": "24675"
    },
    {
      "id": 49742,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1644",
      "transaction_price": "270.35",
      "transaction_type": "F",
      "shares_after_transaction": "33963"
    },
    {
      "id": 49769,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "3030",
      "transaction_price": "270.35",
      "transaction_type": "F",
      "shares_after_transaction": "24675"
    },
    {
      "id": 84944,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-11-01",
      "transaction_shares": "1644",
      "transaction_price": "270.35",
      "transaction_type": "F",
      "shares_after_transaction": "33963"
    },
    {
      "id": 84986,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "3030",
      "transaction_price": "270.35",
      "transaction_type": "F",
      "shares_after_transaction": "24675"
    },
    {
      "id": 10923,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-22",
      "transaction_shares": "200",
      "transaction_price": "249.96",
      "transaction_type": "S",
      "shares_after_transaction": "5301"
    },
    {
      "id": 10971,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-08-22",
      "transaction_shares": "400",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47484"
    },
    {
      "id": 26150,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-22",
      "transaction_shares": "200",
      "transaction_price": "249.96",
      "transaction_type": "S",
      "shares_after_transaction": "5301"
    },
    {
      "id": 26205,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-08-22",
      "transaction_shares": "400",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47484"
    },
    {
      "id": 49690,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-22",
      "transaction_shares": "200",
      "transaction_price": "249.96",
      "transaction_type": "S",
      "shares_after_transaction": "5301"
    },
    {
      "id": 49762,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-08-22",
      "transaction_shares": "400",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47484"
    },
    {
      "id": 84868,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-22",
      "transaction_shares": "200",
      "transaction_price": "249.96",
      "transaction_type": "S",
      "shares_after_transaction": "5301"
    },
    {
      "id": 84977,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-08-22",
      "transaction_shares": "400",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47484"
    },
    {
      "id": 10952,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-18",
      "transaction_shares": "6600",
      "transaction_price": "248.9966",
      "transaction_type": "S",
      "shares_after_transaction": "21184"
    },
    {
      "id": 26179,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-18",
      "transaction_shares": "6600",
      "transaction_price": "248.9966",
      "transaction_type": "S",
      "shares_after_transaction": "21184"
    },
    {
      "id": 49727,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-18",
      "transaction_shares": "6600",
      "transaction_price": "248.9966",
      "transaction_type": "S",
      "shares_after_transaction": "21184"
    },
    {
      "id": 84924,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-18",
      "transaction_shares": "6600",
      "transaction_price": "248.9966",
      "transaction_type": "S",
      "shares_after_transaction": "21184"
    },
    {
      "id": 10965,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "20000",
      "transaction_price": "85.59",
      "transaction_type": "M",
      "shares_after_transaction": "34575"
    },
    {
      "id": 26197,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "20000",
      "transaction_price": "85.59",
      "transaction_type": "M",
      "shares_after_transaction": "34575"
    },
    {
      "id": 49754,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "20000",
      "transaction_price": "85.59",
      "transaction_type": "M",
      "shares_after_transaction": "34575"
    },
    {
      "id": 84963,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "20000",
      "transaction_price": "85.59",
      "transaction_type": "M",
      "shares_after_transaction": "34575"
    },
    {
      "id": 10925,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "634",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "634"
    },
    {
      "id": 10927,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "130.8584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2069.5998"
    },
    {
      "id": 10943,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "130.8584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9814.6749"
    },
    {
      "id": 26152,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "634",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "634"
    },
    {
      "id": 26154,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "130.8584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2069.5998"
    },
    {
      "id": 26170,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "130.8584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9814.6749"
    },
    {
      "id": 49692,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "634",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "634"
    },
    {
      "id": 49694,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "130.8584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2069.5998"
    },
    {
      "id": 49717,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "130.8584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9814.6749"
    },
    {
      "id": 84870,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "634",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "634"
    },
    {
      "id": 84872,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "130.8584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2069.5998"
    },
    {
      "id": 84912,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-09",
      "transaction_shares": "130.8584",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9814.6749"
    },
    {
      "id": 10928,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-07-31",
      "transaction_shares": "1229",
      "transaction_price": "247.47",
      "transaction_type": "F",
      "shares_after_transaction": "13728"
    },
    {
      "id": 10970,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-07-31",
      "transaction_shares": "217",
      "transaction_price": "247.47",
      "transaction_type": "F",
      "shares_after_transaction": "7158"
    },
    {
      "id": 26155,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-07-31",
      "transaction_shares": "1229",
      "transaction_price": "247.47",
      "transaction_type": "F",
      "shares_after_transaction": "13728"
    },
    {
      "id": 26204,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-07-31",
      "transaction_shares": "217",
      "transaction_price": "247.47",
      "transaction_type": "F",
      "shares_after_transaction": "7158"
    },
    {
      "id": 49695,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-07-31",
      "transaction_shares": "1229",
      "transaction_price": "247.47",
      "transaction_type": "F",
      "shares_after_transaction": "13728"
    },
    {
      "id": 49761,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-07-31",
      "transaction_shares": "217",
      "transaction_price": "247.47",
      "transaction_type": "F",
      "shares_after_transaction": "7158"
    },
    {
      "id": 84876,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-07-31",
      "transaction_shares": "1229",
      "transaction_price": "247.47",
      "transaction_type": "F",
      "shares_after_transaction": "13728"
    },
    {
      "id": 84976,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-07-31",
      "transaction_shares": "217",
      "transaction_price": "247.47",
      "transaction_type": "F",
      "shares_after_transaction": "7158"
    },
    {
      "id": 1597,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-23",
      "transaction_shares": "600",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "5501"
    },
    {
      "id": 10929,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-23",
      "transaction_shares": "600",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "5501"
    },
    {
      "id": 26156,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-23",
      "transaction_shares": "600",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "5501"
    },
    {
      "id": 49696,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-23",
      "transaction_shares": "600",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "5501"
    },
    {
      "id": 84878,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-23",
      "transaction_shares": "600",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "5501"
    },
    {
      "id": 1600,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4886"
    },
    {
      "id": 1602,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9607.8165"
    },
    {
      "id": 1608,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6101"
    },
    {
      "id": 1613,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2120"
    },
    {
      "id": 1619,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13579"
    },
    {
      "id": 1622,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1930.7414"
    },
    {
      "id": 1627,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6654.1585"
    },
    {
      "id": 1628,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14461"
    },
    {
      "id": 1631,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10716"
    },
    {
      "id": 1634,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4600"
    },
    {
      "id": 1635,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "SUGAR RONALD D",
      "reporting_owner_cik": "0001216519",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18156"
    },
    {
      "id": 10932,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4886"
    },
    {
      "id": 10934,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9607.8165"
    },
    {
      "id": 10940,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6101"
    },
    {
      "id": 10946,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2120"
    },
    {
      "id": 10953,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13579"
    },
    {
      "id": 10956,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1930.7414"
    },
    {
      "id": 10961,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6654.1585"
    },
    {
      "id": 10962,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14461"
    },
    {
      "id": 10966,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10716"
    },
    {
      "id": 10969,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4600"
    },
    {
      "id": 10972,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "SUGAR RONALD D",
      "reporting_owner_cik": "0001216519",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18156"
    },
    {
      "id": 26159,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4886"
    },
    {
      "id": 26161,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9607.8165"
    },
    {
      "id": 26167,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6101"
    },
    {
      "id": 26173,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2120"
    },
    {
      "id": 26180,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13579"
    },
    {
      "id": 26185,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1930.7414"
    },
    {
      "id": 26193,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6654.1585"
    },
    {
      "id": 26194,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14461"
    },
    {
      "id": 26199,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10716"
    },
    {
      "id": 26203,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4600"
    },
    {
      "id": 26207,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "SUGAR RONALD D",
      "reporting_owner_cik": "0001216519",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18156"
    },
    {
      "id": 49701,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4886"
    },
    {
      "id": 49704,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9607.8165"
    },
    {
      "id": 49713,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6101"
    },
    {
      "id": 49720,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2120"
    },
    {
      "id": 49729,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13579"
    },
    {
      "id": 49738,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1930.7414"
    },
    {
      "id": 49748,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6654.1585"
    },
    {
      "id": 49749,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14461"
    },
    {
      "id": 49756,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10716"
    },
    {
      "id": 49760,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4600"
    },
    {
      "id": 49765,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "SUGAR RONALD D",
      "reporting_owner_cik": "0001216519",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18156"
    },
    {
      "id": 84883,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4886"
    },
    {
      "id": 84889,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9607.8165"
    },
    {
      "id": 84905,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6101"
    },
    {
      "id": 84916,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2120"
    },
    {
      "id": 84926,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13579"
    },
    {
      "id": 84940,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1930.7414"
    },
    {
      "id": 84954,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6654.1585"
    },
    {
      "id": 84956,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14461"
    },
    {
      "id": 84967,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10716"
    },
    {
      "id": 84974,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4600"
    },
    {
      "id": 84981,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "SUGAR RONALD D",
      "reporting_owner_cik": "0001216519",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-17",
      "transaction_shares": "855",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18156"
    },
    {
      "id": 1603,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-12",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "35333"
    },
    {
      "id": 10935,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-12",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "35333"
    },
    {
      "id": 26162,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-12",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "35333"
    },
    {
      "id": 49706,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-12",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "35333"
    },
    {
      "id": 84893,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-12",
      "transaction_shares": "2000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "35333"
    },
    {
      "id": 1617,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-10",
      "transaction_shares": "13500",
      "transaction_price": "241.8114",
      "transaction_type": "S",
      "shares_after_transaction": "37333"
    },
    {
      "id": 10950,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-10",
      "transaction_shares": "13500",
      "transaction_price": "241.8114",
      "transaction_type": "S",
      "shares_after_transaction": "37333"
    },
    {
      "id": 26177,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-10",
      "transaction_shares": "13500",
      "transaction_price": "241.8114",
      "transaction_type": "S",
      "shares_after_transaction": "37333"
    },
    {
      "id": 49725,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-10",
      "transaction_shares": "13500",
      "transaction_price": "241.8114",
      "transaction_type": "S",
      "shares_after_transaction": "37333"
    },
    {
      "id": 84922,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-10",
      "transaction_shares": "13500",
      "transaction_price": "241.8114",
      "transaction_type": "S",
      "shares_after_transaction": "37333"
    },
    {
      "id": 1594,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-05",
      "transaction_shares": "2017",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "619841"
    },
    {
      "id": 1595,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "37",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "7344"
    },
    {
      "id": 1596,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-05",
      "transaction_shares": "49",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "6006"
    },
    {
      "id": 1614,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "575",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50307"
    },
    {
      "id": 1615,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-05",
      "transaction_shares": "603",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "47784"
    },
    {
      "id": 1620,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "27340"
    },
    {
      "id": 1623,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "57661"
    },
    {
      "id": 1625,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "15",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "9404"
    },
    {
      "id": 1629,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-05",
      "transaction_shares": "574",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50833"
    },
    {
      "id": 1636,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "52",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "14869"
    },
    {
      "id": 10922,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-05",
      "transaction_shares": "2017",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "619841"
    },
    {
      "id": 10924,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "37",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "7344"
    },
    {
      "id": 10926,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-05",
      "transaction_shares": "49",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "6006"
    },
    {
      "id": 10947,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "575",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50307"
    },
    {
      "id": 10948,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-05",
      "transaction_shares": "603",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "47784"
    },
    {
      "id": 10954,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "27340"
    },
    {
      "id": 10957,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "57661"
    },
    {
      "id": 10959,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "15",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "9404"
    },
    {
      "id": 10963,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-05",
      "transaction_shares": "574",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50833"
    },
    {
      "id": 10973,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "52",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "14869"
    },
    {
      "id": 26149,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-05",
      "transaction_shares": "2017",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "619841"
    },
    {
      "id": 26151,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "37",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "7344"
    },
    {
      "id": 26153,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-05",
      "transaction_shares": "49",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "6006"
    },
    {
      "id": 26174,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "575",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50307"
    },
    {
      "id": 26175,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-05",
      "transaction_shares": "603",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "47784"
    },
    {
      "id": 26181,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "27340"
    },
    {
      "id": 26186,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "57661"
    },
    {
      "id": 26191,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "15",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "9404"
    },
    {
      "id": 26195,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-05",
      "transaction_shares": "574",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50833"
    },
    {
      "id": 26211,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "52",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "14869"
    },
    {
      "id": 49689,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-05",
      "transaction_shares": "2017",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "619841"
    },
    {
      "id": 49691,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "37",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "7344"
    },
    {
      "id": 49693,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-05",
      "transaction_shares": "49",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "6006"
    },
    {
      "id": 49722,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "575",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50307"
    },
    {
      "id": 49723,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-05",
      "transaction_shares": "603",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "47784"
    },
    {
      "id": 49730,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "27340"
    },
    {
      "id": 49739,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "57661"
    },
    {
      "id": 49746,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "15",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "9404"
    },
    {
      "id": 49750,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-05",
      "transaction_shares": "574",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50833"
    },
    {
      "id": 49771,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "52",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "14869"
    },
    {
      "id": 84865,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-05",
      "transaction_shares": "2017",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "619841"
    },
    {
      "id": 84869,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "37",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "7344"
    },
    {
      "id": 84871,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-05",
      "transaction_shares": "49",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "6006"
    },
    {
      "id": 84918,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-05",
      "transaction_shares": "575",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50307"
    },
    {
      "id": 84919,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-05",
      "transaction_shares": "603",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "47784"
    },
    {
      "id": 84927,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "27340"
    },
    {
      "id": 84941,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-05",
      "transaction_shares": "589",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "57661"
    },
    {
      "id": 84951,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "15",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "9404"
    },
    {
      "id": 84958,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-05",
      "transaction_shares": "574",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "50833"
    },
    {
      "id": 84989,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-05",
      "transaction_shares": "52",
      "transaction_price": "236.10",
      "transaction_type": "F",
      "shares_after_transaction": "14869"
    },
    {
      "id": 1593,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "649",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14978"
    },
    {
      "id": 1598,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-02",
      "transaction_shares": "4330",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49195"
    },
    {
      "id": 1604,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "433",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9437"
    },
    {
      "id": 1605,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "606",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7434"
    },
    {
      "id": 1609,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-02",
      "transaction_shares": "13781",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "624550"
    },
    {
      "id": 1611,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "58958"
    },
    {
      "id": 1621,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3377",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51973"
    },
    {
      "id": 1624,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27929"
    },
    {
      "id": 1626,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1075.7414"
    },
    {
      "id": 1630,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8752.8165"
    },
    {
      "id": 1632,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51652"
    },
    {
      "id": 1633,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-02",
      "transaction_shares": "866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6109"
    },
    {
      "id": 10921,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "649",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14978"
    },
    {
      "id": 10930,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-02",
      "transaction_shares": "4330",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49195"
    },
    {
      "id": 10936,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "433",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9437"
    },
    {
      "id": 10937,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "606",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7434"
    },
    {
      "id": 10941,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-02",
      "transaction_shares": "13781",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "624550"
    },
    {
      "id": 10944,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "58958"
    },
    {
      "id": 10955,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3377",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51973"
    },
    {
      "id": 10958,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27929"
    },
    {
      "id": 10960,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1075.7414"
    },
    {
      "id": 10964,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8752.8165"
    },
    {
      "id": 10967,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51652"
    },
    {
      "id": 10968,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-02",
      "transaction_shares": "866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6109"
    },
    {
      "id": 26148,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "649",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14978"
    },
    {
      "id": 26157,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-02",
      "transaction_shares": "4330",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49195"
    },
    {
      "id": 26163,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "433",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9437"
    },
    {
      "id": 26164,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "606",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7434"
    },
    {
      "id": 26168,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-02",
      "transaction_shares": "13781",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "624550"
    },
    {
      "id": 26171,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "58958"
    },
    {
      "id": 26184,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3377",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51973"
    },
    {
      "id": 26188,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27929"
    },
    {
      "id": 26192,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1075.7414"
    },
    {
      "id": 26196,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8752.8165"
    },
    {
      "id": 26201,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51652"
    },
    {
      "id": 26202,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-02",
      "transaction_shares": "866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6109"
    },
    {
      "id": 49688,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "649",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14978"
    },
    {
      "id": 49698,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-02",
      "transaction_shares": "4330",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49195"
    },
    {
      "id": 49707,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "433",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9437"
    },
    {
      "id": 49709,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "606",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7434"
    },
    {
      "id": 49714,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-02",
      "transaction_shares": "13781",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "624550"
    },
    {
      "id": 49718,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "58958"
    },
    {
      "id": 49737,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3377",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51973"
    },
    {
      "id": 49743,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27929"
    },
    {
      "id": 49747,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1075.7414"
    },
    {
      "id": 49751,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8752.8165"
    },
    {
      "id": 49758,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51652"
    },
    {
      "id": 49759,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-02",
      "transaction_shares": "866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6109"
    },
    {
      "id": 84864,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "649",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14978"
    },
    {
      "id": 84880,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP Global Commercial Ops",
      "transaction_date": "2022-05-02",
      "transaction_shares": "4330",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49195"
    },
    {
      "id": 84895,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "433",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9437"
    },
    {
      "id": 84897,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "606",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "7434"
    },
    {
      "id": 84907,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-05-02",
      "transaction_shares": "13781",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "624550"
    },
    {
      "id": 84913,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3637",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "58958"
    },
    {
      "id": 84938,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3377",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51973"
    },
    {
      "id": 84945,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27929"
    },
    {
      "id": 84952,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1075.7414"
    },
    {
      "id": 84959,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-02",
      "transaction_shares": "140.7414",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8752.8165"
    },
    {
      "id": 84969,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-05-02",
      "transaction_shares": "3897",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "51652"
    },
    {
      "id": 84973,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-05-02",
      "transaction_shares": "866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6109"
    },
    {
      "id": 1599,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "55321"
    },
    {
      "id": 1601,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "28",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "6828"
    },
    {
      "id": 1606,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "48596"
    },
    {
      "id": 1607,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-04-27",
      "transaction_shares": "2547",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "610769"
    },
    {
      "id": 1610,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "184",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "47755"
    },
    {
      "id": 1612,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "60",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "14329"
    },
    {
      "id": 1616,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-04-27",
      "transaction_shares": "273",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "5243"
    },
    {
      "id": 1618,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "17",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "9004"
    },
    {
      "id": 10931,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "55321"
    },
    {
      "id": 10933,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "28",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "6828"
    },
    {
      "id": 10938,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "48596"
    },
    {
      "id": 10939,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-04-27",
      "transaction_shares": "2547",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "610769"
    },
    {
      "id": 10942,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "184",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "47755"
    },
    {
      "id": 10945,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "60",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "14329"
    },
    {
      "id": 10949,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-04-27",
      "transaction_shares": "273",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "5243"
    },
    {
      "id": 10951,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "17",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "9004"
    },
    {
      "id": 26158,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "55321"
    },
    {
      "id": 26160,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "28",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "6828"
    },
    {
      "id": 26165,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "48596"
    },
    {
      "id": 26166,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-04-27",
      "transaction_shares": "2547",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "610769"
    },
    {
      "id": 26169,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "184",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "47755"
    },
    {
      "id": 26172,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "60",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "14329"
    },
    {
      "id": 26176,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-04-27",
      "transaction_shares": "273",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "5243"
    },
    {
      "id": 26178,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "17",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "9004"
    },
    {
      "id": 49699,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "55321"
    },
    {
      "id": 49702,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "28",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "6828"
    },
    {
      "id": 49710,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "48596"
    },
    {
      "id": 49712,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-04-27",
      "transaction_shares": "2547",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "610769"
    },
    {
      "id": 49715,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "184",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "47755"
    },
    {
      "id": 49719,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "60",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "14329"
    },
    {
      "id": 49724,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-04-27",
      "transaction_shares": "273",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "5243"
    },
    {
      "id": 49726,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "17",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "9004"
    },
    {
      "id": 84881,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "55321"
    },
    {
      "id": 84885,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "28",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "6828"
    },
    {
      "id": 84898,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP, Gen. Counsel & Secy.",
      "transaction_date": "2022-04-27",
      "transaction_shares": "599",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "48596"
    },
    {
      "id": 84904,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2022-04-27",
      "transaction_shares": "2547",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "610769"
    },
    {
      "id": 84909,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP, Research and Development",
      "transaction_date": "2022-04-27",
      "transaction_shares": "184",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "47755"
    },
    {
      "id": 84915,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "60",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "14329"
    },
    {
      "id": 84920,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2022-04-27",
      "transaction_shares": "273",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "5243"
    },
    {
      "id": 84923,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Louie Linda H.",
      "reporting_owner_cik": "0001818953",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2022-04-27",
      "transaction_shares": "17",
      "transaction_price": "249.87",
      "transaction_type": "F",
      "shares_after_transaction": "9004"
    }
  ]
}